(2 minutes read)
The Kenyan government said that Moderna’s Sh57.5 billion vaccine plant would have a crucial role to play in the fight against diseases other than Covid 19 pandemic.
The Kenyan government said that Moderna’s Sh57.5 billion vaccine plant would have a crucial role to play in the fight against diseases other than Covid 19 pandemic.
This decision from the pharma major has come amidst the global glut of coronavirus vaccines. There are reports of global vaccine oversupply, casting doubts on the viability of Covid-19 plants in the pipeline.
Also Read:
https://trendsnafrica.com/kenyan-shilling-plunges-to-an-all-time-low/
https://trendsnafrica.com/fuel-shortage-in-kenya-acute/
But health Cabinet secretary Mutahi Kagwe said vaccine plants in the pipeline including the Moderna’s would also produce other vaccines and the Covid-19 vaccines glut would not affect the construction plans. He rebutted the view that the production glut of Covid-19 vaccines could derail Kenya’s and the rest of Africa’s plan to build vaccine plants.
